Zephyr AI, Inc. ("Zephyr AI"), a leader in precision medicine harnessing artificial intelligence to accelerate drug development, today announced its schedule of research presentations at the American ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
Presented in collaboration with the National Cancer Centre Singapore, this study marks the first validation of the ArteraAI Prostate Test in an Asian prostate cancer population. The test was shown to ...
LONDON, ENGLAND - APRIL 04: Ai-Da Robot, an ultra-realistic humanoid robot artist, paints during a press call at The British Library on April 4, 2022 in London, England. Ai-Da will open her solo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results